207
A 14-year-old female developed systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA) two weeks after administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy.
 A 14-year-old female: Subject; 14-year-old: Subject.Age; female: Subject.Gender; systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA): Effect; administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy: Treatment; carbamazepine: Treatment.Drug; benign Rolandic epilepsy: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 A 14-year-old female: Subject; 14-year-old: Subject.Age; female: Subject.Gender; systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA): Effect; administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy: Treatment; carbamazepine: Treatment.Drug; benign Rolandic epilepsy: Treatment.Disorder